secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCA Healthcare, Inc. (HCA)
CIK:        0000860730
Form:       8-K
Filed at:   2023-04-21T23:59:59+00:00
Accession:  0001193125-23-109258
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCA Healthcare Q1 EPS $4.85 beats prior year; raises 2023 revenue and profit guidance
--------------------------------------------------------------------------------

- Q1 revenues $15.591B (up 4.3% YoY); net income $1.363B, diluted EPS $4.85 vs $4.14.
- Adjusted EBITDA $3.172B vs $2.944B; same facility admissions +4.4%, equivalent admissions +7.5%.
- Board declared $0.60/share dividend payable June 30, 2023, record June 16.
- Repurchased 3.34M shares for $846M in Q1; $3.74B remaining under authorization.
- 2023 guidance raised: revenue $62.5-64.5B; EPS $17.25-18.55; Adjusted EBITDA $12.1-12.7B.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/0001193125-23-109258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/860730/000119312523109258/d431466d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-109258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer